Sentry Petroleum Ltd (SPLM)
Sentry Petroleum Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Denver, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $4,745. On trailing twelve-month figures it carries a trailing P/E of -0.09, a net margin of 0.0%. Its beta of 20.58 implies it has historically moved more than the broad market.
Sentry Petroleum Ltd. (SPLM) operates as an early-stage energy company, primarily focused on the acquisition, exploration, and development of oil and natural gas properties. The firm possesses a full 100% ownership interest in four distinct exploration permits, specifically ATPs 862, 864, 865, and 866. These substantial concessions collectively cover an expansive region of roughly 6.9 million net acres within Queensland's Adavale Basin. Founded in 2006, the company initially operated as Summit Exploration Inc. before rebranding to Sentry Petroleum Ltd. in December 2007. Its corporate headquarters are situated in Denver, Colorado.
Sentry Petroleum Ltd is most often compared with the following Healthcare names: